Dermatology · San Antonio, TX
NPI
1124181615
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3320 Oakwell Ct
San Antonio, TX, 78218
Phone (210) 829-5180
Groups this clinician bills Medicare through
Medicare paid, 2024
$469K
27,989 services
Medicare patients, 2024
1,552
Average age 73
Drug cost, 2024
$2.6M
3,116 prescriptions
Company payments, 2025
$96K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John C Browning was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 17,800 times for 22 patients. In total John C Browning billed 27,989 services in 98 codes, and Medicare paid $469K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-06.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 17,800 | 22 | $1.32 | $23K |
| 17003 Destruction Skin Lesion | Office | 3,127 | 501 | $4.81 | $15K |
| 99213 Office E&M - Established | Office | 1,445 | 993 | $59.95 | $87K |
| 95044 Test - Miscellaneous | Office | 1,143 | 14 | $3.44 | $3,935 |
| 17000 Destruction Skin Lesion | Office | 854 | 622 | $36.22 | $31K |
| 11102 Skin Biopsy | Office | 508 | 444 | $63.19 | $32K |
| 17110 Destruction Skin Lesion | Office | 479 | 390 | $77.55 | $37K |
| 99214 Office E&M - Established | Office | 358 | 246 | $90.14 | $32K |
| 99203 Office E&M - New | Office | 331 | 331 | $65.85 | $22K |
| 77401 Conventional Radiation Treatment | Office | 288 | 21 | $32.56 | $9,378 |
| 77280 Radiation Treatment Planning | Office | 222 | 21 | $210.57 | $47K |
| 96910 Skin | Office | 210 | 14 | $90.15 | $19K |
| 11103 Skin Biopsy | Office | 137 | 86 | $38.33 | $5,251 |
| 99212 Office E&M - Established | Office | 115 | 105 | $37.12 | $4,269 |
| 17004 Destruction Skin Lesion | Office | 112 | 96 | $119.21 | $13K |
By year: 2022 $391K for 16,605 services; 2023 $433K for 20,251 services; 2024 $469K for 27,989 services.
Medicare prescription drug claims, 2024
In 2024, the drug John C Browning prescribed most often to Medicare patients was Ketoconazole, with 418 prescriptions and refills. In total John C Browning wrote 3,116 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 418 | 435 | 148 | $5,734 |
| Triamcinolone Acetonide Generic | 364 | 413 | 181 | $5,030 |
| Clobetasol Propionate Generic | 295 | 307 | 143 | $13K |
| Doxycycline Hyclate Generic | 156 | 229 | 75 | $4,388 |
| Ammonium Lactate Generic | 155 | 179 | 73 | $2,775 |
| Minoxidil Generic | 126 | 238 | 32 | $1,286 |
| Mometasone Furoate Generic | 102 | 103 | 41 | $1,788 |
| Mupirocin Generic | 93 | 99 | 66 | $666 |
| Fluocinolone Acetonide Generic | 75 | 77 | 19 | $3,443 |
| Dupixent Pen Dupilumab | 68 | 70 | Under 11 | $274K |
| Fluocinonide Generic | 66 | 71 | 28 | $2,814 |
| Hydrocortisone Generic | 53 | 67 | 29 | $1,235 |
| Clindamycin Phosphate Generic | 47 | 48 | 13 | $1,365 |
| Dupixent Syringe Dupilumab | 46 | 52 | Under 11 | $198K |
| Latanoprost Generic | 45 | 64 | 11 | $289 |
Brand drugs: - claims; generic drugs: 2,695 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John C Browning $96K ($95K in general payments such as food, travel and fees and $1,160 for research) from 32 companies. The largest payer was Galderma Laboratories, L.P. with $54K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 51 | $54K |
| Krystal Biotech Inc KRYS | 27 | $18K |
| Regeneron Healthcare Solutions, Inc. REGN | 18 | $9,699 |
| Pfizer Inc. PFE | 16 | $5,054 |
| Genzyme Corporation SNY | 12 | $4,572 |
| Regeneron Pharmaceuticals, Inc. REGN | 7 | $1,160 |
| Organon LLC OGN | 12 | $894 |
| Nobelpharma America, LLC | 1 | $700 |
| Abbvie Inc. ABBV | 24 | $519 |
| UCB, Inc. UCB.BR | 10 | $346 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.